June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Sensitivity to netilmicin in infectious keratitis in Mexico in the period 2009 to 2017.
Author Affiliations & Notes
  • Francisco Beltran
    Cornea and Refractive Surgery, Asociacion para Evitar la Ceguera IAP Hospital Dr Luis Sanchez Bulnes, Mexico City, Mexico City, Mexico
  • Kristian Vázquez-Rom
    Cornea and Refractive Surgery, Asociacion para Evitar la Ceguera IAP Hospital Dr Luis Sanchez Bulnes, Mexico City, Mexico City, Mexico
  • José Arturo Oyervides-Alvarado
    Cornea and Refractive Surgery, Asociacion para Evitar la Ceguera IAP Hospital Dr Luis Sanchez Bulnes, Mexico City, Mexico City, Mexico
  • Laura Alejandra González-Dibildox
    Cornea and Refractive Surgery, Asociacion para Evitar la Ceguera IAP Hospital Dr Luis Sanchez Bulnes, Mexico City, Mexico City, Mexico
  • Nallely Ramos Betancourt
    Cornea and Refractive Surgery, Asociacion para Evitar la Ceguera IAP Hospital Dr Luis Sanchez Bulnes, Mexico City, Mexico City, Mexico
  • Manuel Garza Leon
    Universidad de Monterrey Division de Ciencias de la Salud, San Pedro Garza Garcia, Nuevo León, Mexico
  • Everardo Hernandez-Quintela
    Cornea and Refractive Surgery, Asociacion para Evitar la Ceguera IAP Hospital Dr Luis Sanchez Bulnes, Mexico City, Mexico City, Mexico
  • Footnotes
    Commercial Relationships   Francisco Beltran, SIFI (F); Kristian Vázquez-Rom, None; José Oyervides-Alvarado, None; Laura González-Dibildox, None; Nallely Ramos Betancourt, None; Manuel Garza Leon, Alcon (C), S4Optik (F), SIFI (F); Everardo Hernandez-Quintela, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 410. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Francisco Beltran, Kristian Vázquez-Rom, José Arturo Oyervides-Alvarado, Laura Alejandra González-Dibildox, Nallely Ramos Betancourt, Manuel Garza Leon, Everardo Hernandez-Quintela; Sensitivity to netilmicin in infectious keratitis in Mexico in the period 2009 to 2017.. Invest. Ophthalmol. Vis. Sci. 2021;62(8):410.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The 4th generation quinolones are the treatment of choice for infectious bacterial keratitis, however, recent reports suggest an increase in resistance to these drugs, so it is important to recognize the sensitivity of other drugs and compare them with the gold standard

Methods : A cross-sectional study including a consecutive analysis of patients records with a diagnosis of bacterial keratitis with a positive culture and antibiogram report between January 2009 and December 2017 of the Cornea department of the Dr. Luis Sánchez Bulnes Hospital of the Association to Avoid Blindness in Mexico were included. Demographic data, Gram stain, bacterial profile and antimicrobial resistance were analyzed.

Results : In the studied period, a total of 794 (49.53%) cases with a positive culture were included. 27.1% of patients had polymicrobial infections so 1034 cultures were evaluated. 52.3% of the patients were male, the mean age was 48.28 ± 20.43 years (range 1 to 97 years). 81.33% (841) of the cultures were gram positive. The antibiotic with the highest sensitivity for gram positive was Netilmicin (93.23%), followed by Moxifloxacin (92.98%) and Gatifloxacin (92.39%). For gram negative cultures again Netilmicin had the highest sensitivity (88.08%), followed by Gatifloxacin (86.01%) and Moxifloxacin (84.45%).

Conclusions : Gram positive bacterias are the most common cause of infectious keratitis, Staphylococcus and Pseudomonas as the most common isolates. Netilmicine and 4th generation flouroquinolones had a very good sensibility for both types of bacteria.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×